CD4 and neoplasm: A lower SpatialScore (i.e., CD4+ T cells are closer to tumor cells than Tregs) suggests increased T cell effector activity (Fig. 4a.1), whereas a higher SpatialScore (i.e., CD4+ T cells are closer to Tregs than tumor cells) suggests increased T cell suppression (Fig. 4a.2).